MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 23.88
-0.16 (-0.67%)
At close: Feb 20, 2026
MedinCell Market Cap
MedinCell has a market cap or net worth of €790.5 million as of February 20, 2026. Its market cap has increased by 76.40% in one year.
Market Cap
790.50M
Enterprise Value
810.58M
Revenue
32.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€23.88
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 790.50M, an increase of 441.04%. That is a compound annual growth rate of 25.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 790.50M | -5.24% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 1.08B |
| Inventiva | 1.07B |
| Nanobiotix | 1.06B |
| Valneva SE | 825.33M |
| Genfit | 392.39M |
| Cellectis | 248.80M |
| Transgene | 225.09M |
| MaaT Pharma | 138.87M |